Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 9-oxoODE cPLA2i 1.0 BCD110605C16 1.61 pmol/ml of medium
- 9-oxoODE cPLA2i 1.0 BCD110605C18 1.63 pmol/ml of medium
- 9-oxoODE cPLA2i 1.0 BCD110605C17 2.17 pmol/ml of medium
- 9-oxoODE cPLA2i 4.0 BCD110605C34 2.3 pmol/ml of medium
- 9-oxoODE cPLA2i 4.0 BCD110605C36 1.56 pmol/ml of medium
- 9-oxoODE cPLA2i 4.0 BCD110605C35 1.41 pmol/ml of medium
- 9-oxoODE cPLA2i 20.0 BCD110605C53 1.64 pmol/ml of medium
- 9-oxoODE cPLA2i 20.0 BCD110605C54 0.936 pmol/ml of medium
- 9-oxoODE cPLA2i 20.0 BCD110605C52 1.56 pmol/ml of medium
- 9-oxoODE PLDi 1.0 BCD110605C10 1.91 pmol/ml of medium
- 9-oxoODE PLDi 1.0 BCD110605C12 1.84 pmol/ml of medium
- 9-oxoODE PLDi 1.0 BCD110605C11 1.39 pmol/ml of medium
- 9-oxoODE PLDi 4.0 BCD110605C30 1.49 pmol/ml of medium
- 9-oxoODE PLDi 4.0 BCD110605C29 1.91 pmol/ml of medium
- 9-oxoODE PLDi 4.0 BCD110605C28 1.91 pmol/ml of medium
- 9-oxoODE PLDi 20.0 BCD110605C48 0.577 pmol/ml of medium
- 9-oxoODE PLDi 20.0 BCD110605C47 0.984 pmol/ml of medium
- 9-oxoODE PLDi 20.0 BCD110605C46 0.737 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 1.0 BCD110605C19 1.22 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 1.0 BCD110605C21 1.86 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 1.0 BCD110605C20 2.02 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 4.0 BCD110605C39 1.06 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 4.0 BCD110605C37 1.16 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 4.0 BCD110605C38 1.41 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 20.0 BCD110605C55 0.89 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 20.0 BCD110605C57 0.911 pmol/ml of medium
- 9-oxoODE KDO+cPLA2i 20.0 BCD110605C56 0.962 pmol/ml of medium
- 9-oxoODE KDO+PLDi 1.0 BCD110605C15 1.01 pmol/ml of medium
- 9-oxoODE KDO+PLDi 1.0 BCD110605C14 1.62 pmol/ml of medium
- 9-oxoODE KDO+PLDi 1.0 BCD110605C13 1.26 pmol/ml of medium
- 9-oxoODE KDO+PLDi 4.0 BCD110605C32 1.03 pmol/ml of medium
- 9-oxoODE KDO+PLDi 4.0 BCD110605C31 2 pmol/ml of medium
- 9-oxoODE KDO+PLDi 4.0 BCD110605C33 1.28 pmol/ml of medium
- 9-oxoODE KDO+PLDi 20.0 BCD110605C49 0.827 pmol/ml of medium
- 9-oxoODE KDO+PLDi 20.0 BCD110605C51 0.766 pmol/ml of medium
- 9-oxoODE KDO+PLDi 20.0 BCD110605C50 0.929 pmol/ml of medium
- 9-oxoODE KDO + ATP 1.0 BCD110605C07 1.18 pmol/ml of medium
- 9-oxoODE KDO + ATP 1.0 BCD110605C09 1.17 pmol/ml of medium
- 9-oxoODE KDO + ATP 1.0 BCD110605C08 1.2 pmol/ml of medium
- 9-oxoODE KDO + ATP 4.0 BCD110605C25 0.832 pmol/ml of medium
- 9-oxoODE KDO + ATP 4.0 BCD110605C26 1.34 pmol/ml of medium
- 9-oxoODE KDO + ATP 4.0 BCD110605C27 1.76 pmol/ml of medium
- 9-oxoODE KDO + ATP 20.0 BCD110605C45 0.531 pmol/ml of medium
- 9-oxoODE KDO + ATP 20.0 BCD110605C43 0.432 pmol/ml of medium
- 9-oxoODE KDO + ATP 20.0 BCD110605C44 0.771 pmol/ml of medium
- 9-oxoODE C 0.0 BCD110605C02 1.09 pmol/ml of medium
- 9-oxoODE C 0.0 BCD110605C01 0.911 pmol/ml of medium
- 9-oxoODE C 0.0 BCD110605C03 0.663 pmol/ml of medium
- 9-oxoODE C 1.0 BCD110605C06 1.44 pmol/ml of medium
- 9-oxoODE C 1.0 BCD110605C05 1.4 pmol/ml of medium